NCT00583713View on ClinicalTrials.gov

An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

June 30, 2008

Conditions
ColonoscopyBowel Preparation
Interventions
DRUG

BLI-800

BLI-800 oral solution (two doses)

Trial Locations (1)

Unknown

Minneapolis

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY